Physician profile
Meredith E Demers
NPI 1457928129
$639.04
in general payments reported to CMS, 2019-2025
9 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $99.19 · 2024: $268 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $248.24 | 2025 | Tremfya |
| Eisai INC. | $117.00 | 2023-2024 | |
| Abbvie INC. | $62.82 | 2024 | |
| Merck Sharp & Dohme LLC | $57.15 | 2024 | Keytruda |
| Novartis Pharmaceuticals Corporation | $56.11 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.23 | 2023 | Fruzaqla |
| Ipsen Biopharmaceuticals, INC | $26.53 | 2024 | Onivyde, Somatuline Depot |
| Foundation Medicine, INC. | $25.61 | 2023 | Foundationone Liquid Cdx |
| Spectrum Pharmaceuticals INC. | $18.35 | 2024 | Rolvedon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Demers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.